Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans
By E. Graefe, Joerg Wittig, Silke C Mueller, A. Riethling, Bernhard Uehleke, B. Drewelow, H. Pforte, G. Jacobasch, H. Derendorf, M. Veit. Journal of clinical pharmacology, 2001
634 citations recorded by the source corpus.
Subfields: Biochemistry, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/7b036a019c1f4aee1af703a6d534f0713f5968c4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
- Augustin Scalbert
- Claudine Manach
- C. Rémésy
- C. Morand
- G. Williamson
- I. Erlund
- Eboh Abraham Sisein
- S. Ramos
In Endocrinology, Diabetes and Metabolism
In Pathology and Forensic Medicine
- Augustin Scalbert
- H. Rupasinghe
- S. Thilakarathna
- Claudine Manach
- R. Masella
- G. Williamson
- I. Erlund
- S. Ramos
Citations in the corpus
- Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology (2004, background): “Interindividual variation in bioavailability Several studies indicate marked individual variation in the bioavailability of flavonoids [104,105,113].”
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease (2019, background): “Because senescent cells can takeweeks tomonths to develop and do not divide, and because even eliminating only 30% of senescent cells can be sufficient to alleviate dysfunction in preclinical studies [3,5,7,9,23,24,28,32–37], D+Q is as effective inmice if administered intermittently, for example eve”
- Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid (2016, background): “[56,58] Quercetin with its radical scavenging potential is said to be capable of preventing cancer which is induced by oxidative stress.”
- Polyphenols, dietary sources and bioavailability. (2007, background): “4% of the ingested dose of quercetin and its glycosides [83, 100, 131].”
- Polyphenols: food sources and bioavailability. (2004, background): “75 mol/L after consumption of 80–100 mg quercetin equivalent administered in the form of apples, onions, or meals rich in plant products (90, 92, 107).”
- Flavonoid Bioavailability and Attempts for Bioavailability Enhancement (2013, background): “Flavonols Sugars and their position affects bioavailability [44].”
- A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. (2007, background): “…was not identified in plasma samples following oral administration of the flavonol (Manach et al., 1998; Erlund et al., 2000; Walle et al., 2000; Graefe et al., 2001), more recent trials utilizing improved detection methods have demonstrated trace quantities of the aglycone in the plasma of one…”
- Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. (2005, background): “Generally, 20–40% of quercetin is methylated in the 3'-position, yielding isorhamnetin (31, 34, 38).”